Researchers will investigate effects of COVID-19 vaccine on patients with HIV
Right now, an important question for people living with HIV is whether their immune system responses to COVID vaccines differ from the general population. A new study led by a team of researchers at Johns Hopkins University School of Medicine aims to answer that question.
The purpose of the study is to determine the safety of the COVID-19 vaccine as well as coronavirus antibody levels in patients who receive the vaccine who are living with HIV as part of a larger study looking at a variety of medical conditions. The research team, led by Johns Hopkins Medicine Associate Professor of Surgery Dr. Jacqueline Garonzik Wang, hopes to provide a better understanding of COVID-19 vaccine safety and effectiveness for these patients.
For individuals who have received or will receive a vaccine and are interested in participating, the study involves completing an online survey and collecting a blood sample before vaccination (if you have not yet received the vaccine) and periodically after vaccination through your local LabCorp to determine COVID-19 antibody levels.
There is no cost for participation and results will be shared with participants once they are received from LabCorp.
Please visit http://www.vaccineresponse.org/ to learn more and enroll.